Biocatalytic access to chiral amines

Biocatalytic access to chiral amines
Product Description

We have a large panel of imine reductases (>140). These enzymes have a large substrate scope catalysing the enantioselective synthesis of chiral amines. We offer access to our panel to customers interested in exploring this chemistry.

Enzyan Biocatalysis GmbH

  • Country/Region:
    Austria
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Start-up
Primary activities
Agrochemical
Chemical Development
Contract Research Organisation
Fine Chemicals Company
Technology

Enzyan Biocatalysis GmbH

  • Country/Region:
    Austria
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Start-up
Primary activities
Agrochemical
Chemical Development
Contract Research Organisation
Fine Chemicals Company
Technology

More Products from Enzyan Biocatalysis GmbH (2)

  • Biocatalytic access to hydroxylated products

    Product Biocatalytic access to hydroxylated products

    We have a large panel of 2-oxoglutarate dependent enzymes (>150). These enzymes have a large substrate scope catalysing hydroxylation, epoxidation, desaturation, demethylation reactions. We offer access to our panel to customers interested in exploring this chemistry for derivatizaion of your substrates.
  • Biocatalytic cascade to DMT derivatives

    Product Biocatalytic cascade to DMT derivatives

    We developed and patented a combination of enzymes to access N,N-dimethyltryptamine and its derivatives (5-MeO DMT, psilocybin, psilocin, triptans). We look for strategic partnerships to advance the development of this bioprocess. 

Enzyan Biocatalysis GmbH resources (10)